Print

Novartis Corporation (NVS) Gets FDA Approvable Letter For Aclasta  
2/27/2006 10:30:11 AM

ZURICH, Feb 27 (Reuters) - Swiss drug maker Novartis (NOVN.VX: Quote, Profile, Research) has received an "approvable letter" from U.S. drug regulators for its Aclasta drug for use in the treatment of Paget's disease, a painful bone disorder, the firm said.
//-->